Healthcare, Weight Loss

What Is the Best Weight Loss Injection? Every Option, Compared Honestly

best weight loss injection

QUICK ANSWER

There is no single best weight loss injection for everyone. Three are FDA approved for weight management: Wegovy, Zepbound and Saxenda. Four others people ask about, including Ozempic and Mounjaro, are approved only for type 2 diabetes. B12, lipotropic and HCG injections are not weight loss drugs at all.

KEY TAKEAWAYS

  • Ozempic, Mounjaro, Victoza and Trulicity are approved for type 2 diabetes, not for weight management. Their weight management counterparts are Wegovy, Zepbound and Saxenda.
  • In the only head to head trial, tirzepatide produced 20.2 percent average weight loss against 13.7 percent for semaglutide over 72 weeks.
  • Zepbound is also approved for obstructive sleep apnea in adults with obesity. Wegovy is also approved to reduce cardiovascular event risk and for MASH with advanced fibrosis. Those extra indications often decide the choice.
  • HCG injections carry an FDA mandated label stating in capital letters that HCG has not been demonstrated to be effective for obesity.
  • B12 injections treat B12 deficiency. The NIH states B12 has no beneficial effect on performance in the absence of a nutritional deficit.
  • Weight tends to return after stopping. A 2026 analysis of 9,341 participants found weight returned to baseline on average within about 1.7 years.

Ask what is the best weight loss injection and most pages answer with a ranking. The honest answer is that the question has three parts: which injections are actually approved for weight loss, how they differ, and which one fits your medical history.

This article answers all three. It also covers the injections that are marketed for weight loss but are not weight loss drugs, because that distinction is missing from almost every comparison online.

Four widely discussed injections are not approved for weight loss

This is the most common source of confusion, and it matters because the approved indication determines what a provider can prescribe and what insurance will consider.

Semaglutide and tirzepatide each exist under two different brand names with two different approvals. Same molecule, different product, different indication.

BrandMoleculeFDA approved forFrequency
WegovySemaglutideWeight management. Also reducing major cardiovascular event risk in adults with established cardiovascular disease plus obesity or overweight, and MASH with moderate to advanced fibrosisOnce weekly injection
OzempicSemaglutideType 2 diabetes only. Glycemic control, cardiovascular risk reduction in type 2 diabetes with cardiovascular disease, and kidney outcomes in type 2 diabetes with chronic kidney disease. Not indicated for weight lossOnce weekly injection
ZepboundTirzepatideWeight management. Also moderate to severe obstructive sleep apnea in adults with obesityOnce weekly injection
MounjaroTirzepatideType 2 diabetes only. Not indicated for weight lossOnce weekly injection
SaxendaLiraglutide 3.0 mgWeight management in adults, and in patients 12 and over weighing more than 60 kgOnce daily injection
VictozaLiraglutideType 2 diabetes only. Not indicated for weight lossOnce daily injection
TrulicityDulaglutideType 2 diabetes only. Not indicated for weight lossOnce weekly injection

People do lose weight on Ozempic and Mounjaro. That is a known effect of the molecule, not the approved use of that product. When a prescription is written for weight management, the weight management product is the one that matches the indication.

The FDA approved weight loss injections, compared

InjectionAverage weight change in its main trialTrial detailNotes
Zepbound (tirzepatide)Minus 16.0 percent at 5 mg, minus 21.4 percent at 10 mg, minus 22.5 percent at 15 mg, against minus 2.4 percent on placeboSURMOUNT-1, 72 weeks, 2,539 participants, New England Journal of Medicine 2022Acts on two receptors, GLP-1 and GIP
Wegovy (semaglutide)Minus 14.9 percent against minus 2.4 percent on placeboSTEP 1, 68 weeks, 1,961 participants, 73 percent female, New England Journal of Medicine 2021Acts on the GLP-1 receptor
Saxenda (liraglutide)Minus 8.0 percent against minus 2.6 percent on placeboSCALE, 56 weeks, 3,731 participants, New England Journal of Medicine 2015Daily rather than weekly injection

Trial averages are not predictions. They describe what happened to a group of people under trial conditions, alongside diet and activity support. Our GLP-1 weight loss projection calculator will show you what a given percentage looks like against your own starting weight, which is usually more useful than a percentage in the abstract.

What the head to head trial found

Until recently these medications had only been compared indirectly. SURMOUNT-5 changed that.

The trial randomised 751 adults and ran for 72 weeks. Tirzepatide produced an average 20.2 percent reduction in body weight. Semaglutide produced 13.7 percent. Waist circumference fell 18.4 cm against 13.0 cm. It was published in the New England Journal of Medicine in 2025.

One finding is often left out. Discontinuation for gastrointestinal side effects was lower on tirzepatide at 2.7 percent than on semaglutide at 5.6 percent. The more effective drug was also the better tolerated one in that trial.

That does not settle the choice. We go through how a provider weighs the two in our guide to semaglutide compared with tirzepatide.

The injections that are not weight loss drugs

Search results for the best weight loss injection routinely include three things that are not weight loss medication. Each is worth understanding on its own terms.

HCG injections

The FDA approved label for chorionic gonadotropin carries a statement in capital letters. It reads that HCG “has not been demonstrated to be effective adjunctive therapy in the treatment of obesity,” and that there is “no substantial evidence that it increases weight loss beyond that resulting from caloric restriction.”

The same label adds that HCG “has no known effect on fat mobilization, appetite or sense of hunger, or body fat distribution.” This is not an outside critique. It is the required text on the product’s own label.

Vitamin B12 injections

B12 injections treat B12 deficiency, and for people with pernicious anemia or a malabsorption problem they are genuinely important. The NIH Office of Dietary Supplements states that B12 “appears to have no beneficial effect on performance in the absence of a nutritional deficit.”

B12 is not a weight loss drug. It can matter alongside one, because eating substantially less changes nutrient intake. We cover that separately in our article on B12 and semaglutide.

Lipotropic or MIC injections

MIC stands for methionine, inositol and choline, usually combined with B vitamins. These are compounded preparations. They are not FDA approved drug products, and no FDA approval exists for them as a weight loss treatment.

Being direct about the evidence: we could not identify a position from the FDA, the NIH, Cochrane or a major obesity society evaluating MIC injections for weight loss. The published evidence base is thin. Anyone presenting them as equivalent to a GLP-1 medication is going beyond what the evidence supports. You can read what the AHC Megaburn MIC and B12 injection is and is not on its own page.

NAD+, sermorelin and glutathione are sometimes grouped into these lists too. They are longevity and wellness injections with different purposes, covered in our guide to longevity injections.

How the side effects compare

Gastrointestinal effects are the most common reason people stop. These figures come directly from the FDA labels and are compared against placebo in the same trial.

Side effectWegovy 2.4 mg vs placeboZepbound 15 mg vs placebo
Nausea44 percent vs 16 percent28 percent vs 8 percent
Diarrhea30 percent vs 16 percent23 percent vs 8 percent
Vomiting24 percent vs 6 percent13 percent vs 2 percent
Constipation24 percent vs 11 percent11 percent vs 5 percent

The FDA label notes these reactions were most frequently reported during dose escalation. Most are described as mild to moderate and they generally settle.

Who should not take a GLP-1 injection

Both Wegovy and Zepbound carry a boxed warning, the FDA’s most serious warning category.

The Wegovy warning states that in rodents, semaglutide causes thyroid C-cell tumors at clinically relevant exposures, and that it is unknown whether the same happens in humans. Zepbound carries an equivalent warning based on rat data.

Both are contraindicated in people with a personal or family history of medullary thyroid carcinoma, and in people with Multiple Endocrine Neoplasia syndrome type 2.

  • They are not appropriate during pregnancy, and weight loss offers no benefit to a pregnant patient.
  • They require care in people with a history of pancreatitis or gallbladder disease.
  • Risk of low blood sugar increases when combined with insulin or a sulfonylurea.
  • Serious hypersensitivity to the medication rules it out.

This is not the full list. It is the reason a licensed provider reviews your history before anything is prescribed.

What happens when you stop

This is the question that should shape the decision more than the efficacy ranking, and it is the one most comparisons skip.

In the STEP 1 trial extension, participants who stopped semaglutide regained 11.6 percentage points of body weight over the following 52 weeks, which is roughly two thirds of what they had lost.

A 2026 analysis in the BMJ pooled 37 studies covering 9,341 participants. Weight returned to baseline on average about 1.7 years after stopping. For semaglutide and tirzepatide specifically, first year regain averaged 9.9 kg.

Obesity medicine treats this as expected rather than as failure. These medications manage a chronic condition, and stopping them tends to reverse the effect. We cover what a restart looks like in restarting a GLP-1 after a break.

How to choose the right weight loss injection

Rather than a ranking, here is the reasoning a provider actually works through.

If this describes youWhat it points toward
You have type 2 diabetes as well as obesityA product approved for both, discussed with the prescriber managing your diabetes
You have established cardiovascular diseaseWegovy carries a specific cardiovascular risk reduction indication
You have moderate to severe obstructive sleep apneaZepbound carries a specific indication for this
You have MASH with advanced fibrosisWegovy carries a specific indication for this
You have had significant nausea on a GLP-1 beforeWorth discussing, given the lower gastrointestinal discontinuation rate seen with tirzepatide in SURMOUNT-5
A weekly injection is manageable but a daily one is notRules out Saxenda, which is daily
You have a personal or family history of medullary thyroid carcinoma or MEN 2These medications are contraindicated. Do not proceed
You are pregnant, breastfeeding or trying to conceiveNot appropriate. Speak to your provider about timing

Cost is part of the decision too. Prices vary widely by product, pharmacy and insurance status, and many plans do not cover weight management medication at all. Our GLP-1 cost and savings calculator lets you model what a course would actually cost you.

What about compounded versions

Compounded semaglutide and tirzepatide are prepared by licensed compounding pharmacies. They are not FDA approved products. The FDA does not review them for safety or effectiveness before they are dispensed, and that is an important difference from the branded products described above.

One documented risk is worth knowing. In July 2024 the FDA alerted providers and patients to dosing errors with compounded semaglutide. Patients confused units with milligrams and drew 50 units instead of 5. Reported overdoses ran from 5 to 20 times the intended dose, with effects including vomiting, dehydration, acute pancreatitis and gallstones. Some people were hospitalised.

If you are prescribed a compounded product, make sure you understand the dose in the units marked on your syringe. Our GLP-1 units to mg converter exists for exactly this reason.

Provider and compliance review required The regulatory position on compounded GLP-1 medication has changed repeatedly since 2024 and continues to develop. This section should be checked against the current FDA position immediately before publishing and re-checked periodically after.

Frequently asked questions

What is the best weight loss injection overall?

By average weight reduction in trials, tirzepatide has produced the largest figures, including 22.5 percent at the 15 mg dose in SURMOUNT-1 and 20.2 percent against semaglutide’s 13.7 percent in the head to head SURMOUNT-5 trial. Best for an individual depends on medical history, other conditions, tolerance and cost.

Is Ozempic a weight loss injection?

Ozempic is FDA approved for type 2 diabetes, not for weight management. It contains semaglutide, the same molecule as Wegovy, which is the semaglutide product approved for weight management.

Is Mounjaro approved for weight loss?

No. Mounjaro is approved for type 2 diabetes. Zepbound is the tirzepatide product approved for weight management.

Which weight loss injection has the fewest side effects?

No trial ranks them for tolerability across the board. In SURMOUNT-5, the only head to head comparison, discontinuation for gastrointestinal side effects was 2.7 percent on tirzepatide against 5.6 percent on semaglutide.

Do B12 injections help you lose weight?

Not on their own. B12 injections treat B12 deficiency. The NIH states B12 appears to have no beneficial effect in the absence of a nutritional deficit.

Are lipotropic or MIC injections effective for weight loss?

They are not FDA approved for weight loss and the published evidence base is limited. No major regulatory or scientific body has issued a position supporting them as a weight loss treatment.

Does the HCG diet work?

The FDA approved label for chorionic gonadotropin states that HCG has not been demonstrated to be effective in the treatment of obesity and has no known effect on appetite or fat distribution. Any weight lost on an HCG protocol is attributed to the severe calorie restriction that accompanies it.

How quickly do weight loss injections work?

The trial figures above were measured over 56 to 72 weeks. Doses are increased gradually over the first months, so early weeks are about tolerance rather than results. Individual response varies and no timeline can be promised.

Will I regain the weight if I stop?

Most people regain a substantial amount. The STEP 1 extension found about two thirds of lost weight returned within a year of stopping, and a 2026 BMJ analysis of 9,341 participants found weight returned to baseline on average within roughly 1.7 years.

Can I switch from one weight loss injection to another?

Switching is common and is a clinical decision. Dosing does not transfer directly between molecules, so a switch is planned and supervised rather than swapped.

Are there weight loss injections that are not GLP-1 medications?

Among FDA approved options for weight management, no. Wegovy, Zepbound and Saxenda all act on the GLP-1 receptor, with Zepbound also acting on GIP. B12, lipotropic and HCG injections are not approved weight loss drugs.

What new weight loss injections are coming?

Several are in development, including retatrutide and CagriSema. Neither is FDA approved and neither is available by prescription. Reported trial figures are from company releases and should be read as preliminary.

Where to go from here

The best weight loss injection is the one that matches your medical history, your other conditions and what you can sustain. That is a conversation, not a ranking. Before you have it, our BMI calculator and the wider set of weight loss calculators will give you the numbers a provider will ask about.

You can start a free evaluation with Alternate Health Club. A licensed US provider reviews your information individually and will tell you if treatment is not appropriate for you.

Medical Disclaimer

This article is for general educational purposes and is not medical advice. It does not replace a consultation with a licensed healthcare professional. Compounded medications are not FDA approved. Brand names are used for educational identification only and do not imply any affiliation or endorsement. Do not start, stop or change any medication without speaking to a qualified provider. Individual results vary and no outcome is guaranteed.